AFRO News

MFN pricing is dangerous to drug innovation

Dan Crippen warns MFN drug price controls could slash U.S. pharmaceutical revenues, cut R&D, and stall lifesaving drug development—urging lawmakers to protect innovation while reducing costs.

More audio from AFRO News